Condition: Scleroderma · Systemic Sclerosis · Sponsor: University Hospital, Bordeaux
Systemic sclerosis (SSc) is a severe autoimmune disease associating dysimmunity, vasculopathy and fibrosis. No curative treatment is available. Pre-clinical abnormalities can be found such as specific autoantibodies. The association of Raynaud phenomenon and SSc-specific anti-nuclear antibodies is the hallmark of pre-scleroderma subjects, among who around 47% declare a complete disease after five years. The aim of this study is to assess in this particular population the preventive effect of an anti-platelet treatment.
This description comes directly from the study's public registry record.
Marie-Elise TRUCHETET, Prof · 05.56.79.55.56 · marie-elise.truchetet@chu-bordeaux.fr
Thomas BARNETCHE, PhD · thomas.barnetche@chu-bordeaux.fr
Always discuss trial participation with your own doctor first.
| CH de la Cote Basque - service de rhumatologie | Bayonne, France | Recruiting |
| CHU de Bordeaux - service de Médecine Interne et Maladies Infectieuses | Bordeaux, France | Not Yet Recruiting |
| CHU de Bordeaux - service de rhumatologie | Bordeaux, France | Recruiting |
| CHU de Brest - service de rhumatologie | Brest, France | Recruiting |
| CHU de Grenoble Alpes - service de médecine vasculaire | Grenoble, France | Recruiting |
| CH de Libourne - service de rhumatologie | Libourne, France | Recruiting |
| CH de Mont-de-Marsan - service de rhumatologie | Mont-de-Marsan, France | Recruiting |
| AP-HP - Hôpital Cochin - service de médecine interne | Paris, France | Recruiting |
| CH de Pau - service de médecine interne | Pau, France | Recruiting |
| Service de Médecine Interne et Immunologie Clinique | Rennes, France | Not Yet Recruiting |
| CHU de Toulouse - service de médecine interne | Toulouse, France | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05098704